[1]
S. Susanah, “Potential Use of Patient-Specific Induced Pluripotent Stem Cell for Liver Fibrosis Thalassemia Treatment Management”, Open Access Maced J Med Sci, vol. 10, no. F, pp. 122–128, Feb. 2022.